Matches in Wikidata for { <http://www.wikidata.org/entity/Q88954090> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q88954090 description "article scientifique publié en 2018" @default.
- Q88954090 description "artículu científicu espublizáu n'abril de 2018" @default.
- Q88954090 description "scientific article published on 17 April 2018" @default.
- Q88954090 description "wetenschappelijk artikel" @default.
- Q88954090 description "наукова стаття, опублікована у квітні 2018" @default.
- Q88954090 name "Osimertinib compared docetaxel-bevacizumab as third-line treatment in EGFR T790M mutated non-small-cell lung cancer" @default.
- Q88954090 name "Osimertinib compared docetaxel-bevacizumab as third-line treatment in EGFR T790M mutated non-small-cell lung cancer" @default.
- Q88954090 type Item @default.
- Q88954090 label "Osimertinib compared docetaxel-bevacizumab as third-line treatment in EGFR T790M mutated non-small-cell lung cancer" @default.
- Q88954090 label "Osimertinib compared docetaxel-bevacizumab as third-line treatment in EGFR T790M mutated non-small-cell lung cancer" @default.
- Q88954090 prefLabel "Osimertinib compared docetaxel-bevacizumab as third-line treatment in EGFR T790M mutated non-small-cell lung cancer" @default.
- Q88954090 prefLabel "Osimertinib compared docetaxel-bevacizumab as third-line treatment in EGFR T790M mutated non-small-cell lung cancer" @default.
- Q88954090 P1433 Q88954090-15BF19AC-1C26-44A6-B8CE-A9B75B545616 @default.
- Q88954090 P1476 Q88954090-339BDEA2-313E-4B8E-A9FF-886FA89D73A1 @default.
- Q88954090 P2093 Q88954090-034C117C-9177-4867-9335-4F4A9B5583CD @default.
- Q88954090 P2093 Q88954090-0F10219E-20D4-4F6B-857B-6E92AEE518E5 @default.
- Q88954090 P2093 Q88954090-1BDF84BB-15D3-4DDD-A237-272A638FE469 @default.
- Q88954090 P2093 Q88954090-1C54E555-DEE6-467B-83DF-3E347504D3E0 @default.
- Q88954090 P2093 Q88954090-2148707F-196F-4DCC-B54E-7B39D28B0820 @default.
- Q88954090 P2093 Q88954090-3E5C0D9A-21BF-4BB7-BC68-5B1A3B7008A6 @default.
- Q88954090 P2093 Q88954090-589F1A53-20A1-4BF9-AD72-51AD47A03C37 @default.
- Q88954090 P2093 Q88954090-85BBC2AA-8B9F-4BCB-8CEB-CA0575C2B715 @default.
- Q88954090 P2093 Q88954090-D66F497D-164B-4626-998F-47F1BFF538D5 @default.
- Q88954090 P2093 Q88954090-E29AFAEA-E939-48BE-80F4-1AC5EFC68E94 @default.
- Q88954090 P2093 Q88954090-EC012BCA-BA53-4962-9C5A-80727891B1D1 @default.
- Q88954090 P304 Q88954090-7B60BD76-CD9B-42E1-A020-FF7F7A2158EA @default.
- Q88954090 P31 Q88954090-E1648BC5-90C7-4DEC-A813-455F0BF368BD @default.
- Q88954090 P356 Q88954090-4C868F1F-8A88-4C3B-BE27-C63788E861B3 @default.
- Q88954090 P478 Q88954090-7887CEBA-D166-49EF-AEBB-A75FB061B258 @default.
- Q88954090 P577 Q88954090-EE7D64A1-DA06-40AA-A73C-FEFC59FA52D4 @default.
- Q88954090 P698 Q88954090-4F816A20-9D27-4679-8A72-EA7C2B2E3CE1 @default.
- Q88954090 P921 Q88954090-4DD617CD-F72F-46C8-AA88-ABF4C91444DB @default.
- Q88954090 P356 J.LUNGCAN.2018.04.012 @default.
- Q88954090 P698 29858027 @default.
- Q88954090 P1433 Q641464 @default.
- Q88954090 P1476 "Osimertinib compared docetaxel-bevacizumab as third-line treatment in EGFR T790M mutated non-small-cell lung cancer" @default.
- Q88954090 P2093 "Chuanxin Geng" @default.
- Q88954090 P2093 "Chunling Zhang" @default.
- Q88954090 P2093 "Keke Nie" @default.
- Q88954090 P2093 "Ketao Lan" @default.
- Q88954090 P2093 "Ling Zhang" @default.
- Q88954090 P2093 "Shichao Liu" @default.
- Q88954090 P2093 "Songping Wang" @default.
- Q88954090 P2093 "Xiajuan Xu" @default.
- Q88954090 P2093 "Xingjun Zhuang" @default.
- Q88954090 P2093 "Youxin Ji" @default.
- Q88954090 P2093 "Zhongfa Zhang" @default.
- Q88954090 P304 "5-11" @default.
- Q88954090 P31 Q13442814 @default.
- Q88954090 P356 "10.1016/J.LUNGCAN.2018.04.012" @default.
- Q88954090 P478 "121" @default.
- Q88954090 P577 "2018-04-17T00:00:00Z" @default.
- Q88954090 P698 "29858027" @default.
- Q88954090 P921 Q413299 @default.